MONITORING OF DRUG RESISTANCE IN THERAPY-NAIVE HIV INFECTED PATIENTS AND DETECTION OF AFRICAN HIV SUBTYPES IN HUNGARY

被引:5
|
作者
Kanizsai, Szilvia [1 ]
Ghidan, A. [1 ]
Ujhelyi, Eszter [2 ]
Banhegyi, D. [2 ]
Nagy, K. [1 ]
机构
[1] Semmelweis Univ, Inst Med Microbiol, H-1085 Budapest, Hungary
[2] Szent Laszlo St Ladislas Hosp, Immunol Lab, Budapest, Hungary
关键词
HIV-1 drug resistant mutants; genotyping; therapy-naive HIV-infected patients; HIV-1; subtypes; CRF; IMMUNODEFICIENCY-VIRUS TYPE-1; REVERSE-TRANSCRIPTASE; RECOMBINATION; DIVERSITY; INHIBITORS; MUTATIONS; EMERGENCE; EVOLUTION; DYNAMICS; PROTEASE;
D O I
10.1556/AMicr.57.2010.1.5
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Mutations in the HIV-1 pol gene associated with resistance to antiretroviral drugs in therapy-nave Hungarian individuals transmitted as primary infection by their foreign sexual partners originated from African, Asian and other European countries had been analyzed. Drug resistance genotyping of HIV RT and PR genes were performed where mutations of 72 codons - among them 64 specific resistance codons representing 6 nucleoside reverse transcriptase inhibitor (NRTIs), 2 non-nucleoside reverse transcriptase inhibitor (NNRTIs) and 6 proteinase inhibitor (PRIs) drugs had been analyzed by Truegene HIV-1 Genotyping kit and OpenGene Sequencing System. Viral variants harboring resistance mutations in the pol gene were detected in 14% of the subjects. The highest rate of resistance to a single class of inhibitors was detected towards PR inhibitors (12%), followed by NRTI (8%) and NNRTI (5%). On the contrary, 25% of viruses transmitted by homosexual activity contained mutations led to resistance to NNRT. Viruses from 11 percent of cases were resistant to 2 classes of inhibitors, and 7 percent to three classes of inhibitors. Based upon sequence data non-B subtypes and CRFs were detected in more than 71% of cases. HIV-1 C (10.7%), HIV-F1 (7.2%) and HIV-1 G (3.6%) were detected as the more frequent subtypes. Among the HIV-1 recombinant viruses CRF02 AG variants were found more frequently (28.5%) followed by CRF06_cpx (17.8%) indicating penetration of non-B subtypes and recombinant African variants into Hungary, which raises serious clinical and public health consequences.
引用
收藏
页码:55 / 68
页数:14
相关论文
共 50 条
  • [31] HIV Drug Resistance and Its Impact on Antiretroviral Therapy in Chinese HIV-Infected Patients
    Xing, Hui
    Ruan, Yuhua
    Li, Jingyun
    Shang, Hong
    Zhong, Ping
    Wang, Xia
    Liao, Lingjie
    Li, Hanping
    Zhang, Min
    Xue, Yile
    Wang, Zhe
    Su, Bin
    Liu, Wei
    Dong, Yonghui
    Ma, Yanling
    Li, Huiqin
    Qin, Guangming
    Chen, Lin
    Pan, Xiaohong
    Chen, Xi
    Peng, Guoping
    Fu, Jihua
    Chen, Ray Y.
    Kang, Laiyi
    Shao, Yiming
    [J]. PLOS ONE, 2013, 8 (02):
  • [32] HIV-1 Subtypes and Primary Antiretroviral Resistance Mutations in Antiretroviral Therapy Naive HIV-1 Infected Individuals in Turkey
    Sayan, M.
    Willke, A.
    Ozgunes, N.
    Sargin, F.
    [J]. JAPANESE JOURNAL OF INFECTIOUS DISEASES, 2013, 66 (04) : 306 - 311
  • [33] GW433908/ritonavir once daily in antiretroviral therapy-naive HIV-infected patients: absence of protease resistance at 48 weeks
    MacManus, S
    Yates, PJ
    Elston, RC
    White, S
    Richards, N
    Snowden, W
    [J]. AIDS, 2004, 18 (04) : 651 - 655
  • [34] Microalbuminuria among HIV-infected antiretroviral therapy-naive children in the Democratic Republic of Congo
    Ekulu, Pepe M.
    Aloni, Michel N.
    Harambat, Jerome
    Makulo, Jean Robert R.
    Lepira, Francois B.
    Sumaili, Ernest K.
    Mafuta, Eric M.
    Cochat, Pierre
    Nseka, Nazaire M.
    [J]. PEDIATRIC NEPHROLOGY, 2016, 31 (05) : 769 - 772
  • [35] Microalbuminuria among HIV-infected antiretroviral therapy-naive children in the Democratic Republic of Congo
    Pépé M. Ekulu
    Michel N. Aloni
    Jérôme Harambat
    Jean Robert R. Makulo
    François B. Lepira
    Ernest K. Sumaili
    Eric M. Mafuta
    Pierre Cochat
    Nazaire M. Nseka
    [J]. Pediatric Nephrology, 2016, 31 : 769 - 772
  • [36] HIV-1 drug resistance in treatment-naive, chronically infected patients in Jamaica
    Barrow, Geoffrey J.
    Hylton-Kong, Tina
    Rodriguez, Nayra
    Yamamura, Yasuhiro
    Figueroa, J. Peter
    [J]. ANTIVIRAL THERAPY, 2013, 18 (07) : 941 - 944
  • [37] Prevalence of transmitted drug resistance in hiv-infected treatment-naive patients in Chile
    Palma P, Valeria
    Leiva B, Intty
    Duran P, Magdalena
    Ramos V, Veronica
    Sanchez, Constanza
    Beltran B, Carlos
    Afani S, Alejandro
    Ferrer C, Pablo
    [J]. REVISTA MEDICA DE CHILE, 2020, 148 (11) : 1550 - 1557
  • [38] Frequency of protease and reverse transcriptase drug resistance mutations in naive HIV-infected patients
    Valle-Bahena, Olivia M.
    Ramos-Jimenez, Javier
    Ortiz-Lopez, Rocio
    Revol, Agnes
    Lugo-Trampe, Angel
    Barrera-Saldana, Hugo A.
    Rojas-Martinez, Augusto
    [J]. ARCHIVES OF MEDICAL RESEARCH, 2006, 37 (08) : 1022 - 1027
  • [39] Multimethod Longitudinal HIV Drug Resistance Analysis in Antiretroviral-Therapy-Naive Patients
    Nanfack, Aubin J.
    Redd, Andrew D.
    Bimela, Jude S.
    Ncham, Genesis
    Achem, Emmanuel
    Banin, Andrew N.
    Kirkpatrick, Allison R.
    Porcella, Stephen F.
    Agyingi, Lucy A.
    Meli, Josephine
    Colizzi, Vittorio
    Nadas, Arthur
    Gorny, Miroslaw K.
    Nyambi, Phillipe N.
    Quinn, Thomas C.
    Duerr, Ralf
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2017, 55 (09) : 2785 - 2800
  • [40] Fosamprenavir - A review of its use in the management of antiretroviral therapy-naive patients with HIV infection
    Chapman, TM
    Plosker, GL
    Perry, CM
    [J]. DRUGS, 2004, 64 (18) : 2101 - 2124